REVOLAX FINE w/ LIDOCAINE

Where can I buy this product?

REVOLAX FINE w/ Lidocaine is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support.

Product Information

What is REVOLAX FINE w/ Lidocaine?

REVOLAX FINE w/ Lidocaine is a sterile, viscoelastic, injectable gel composed of cross-linked hyaluronic acid (HA) of non-animal origin (derived from Streptococcus zooepidemicus fermentation), manufactured by Across, South Korea. It is characterized as the lowest viscosity filler within the Revolax product line, featuring a monophasic structure according to the manufacturer.

This formulation contains 24mg/mL of cross-linked hyaluronic acid (lower degree of cross-linking or different particle characteristics compared to Deep/Sub-Q) and includes 0.3% lidocaine hydrochloride to enhance patient comfort during injection. Based on manufacturer claims, it undergoes purification to minimize endotoxins and residual BDDE. It is specifically designed for injection into the superficial dermis to correct fine lines and wrinkles.

Storage: Store according to manufacturer guidelines, typically between 2°C and 25°C (36°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that REVOLAX products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners.

How does REVOLAX FINE w/ Lidocaine work?

REVOLAX FINE w/ Lidocaine is formulated as a low-viscosity HA gel intended for precise injection into the superficial dermis. Its properties allow it to integrate smoothly into the upper skin layers to physically fill and smooth fine, etched-in lines and wrinkles without creating excessive bulk.

The manufacturer states its monophasic structure allows for even distribution. When injected, the HA gel provides immediate correction for superficial imperfections. The HA also helps attract and retain moisture locally, contributing to skin hydration in the treated area. The cross-linking is designed to provide durability suitable for superficial placement.

Treatment results are intended to be immediate. The manufacturer suggests a duration of effect lasting approximately 8 to 12 months, although individual results vary. The integrated lidocaine reduces discomfort during the procedure.

Indications for Use

REVOLAX FINE w/ Lidocaine is typically indicated for adults seeking correction of superficial lines:

• Periorbital lines (crow’s feet).
• Superficial perioral lines (fine vertical lip lines).
• Fine forehead lines.
• Glabellar lines (superficial component).
• Neck lines (necklace lines).

It is generally not intended for significant volume restoration or treating deep folds. Appropriate patient selection and superficial injection techniques are crucial where its use is permitted.

Primary Benefits

• Lowest viscosity formulation in the Revolax line for treating fine superficial lines.
• Designed for smooth integration into the superficial dermis.
• High purity HA with low endotoxin/residual BDDE levels
• Suitable for delicate areas like periorbital and perioral regions.
• Results claimed to last 8-12 months.
• Contains lidocaine for improved patient comfort during injection.

Side Effects and Safety Information

Common side effects expected with superficial HA filler injections include temporary, injection-site related reactions:

• Bruising
• Redness
• Swelling (usually mild)
• Tenderness or Pain
• Itching
• Small bumps or slight unevenness (usually resolves quickly)
• Small hematomas

Severe Adverse Events:
While serious complications are less frequent with superficial injections compared to deep fillers, potential risks exist. Practitioners must be prepared to manage adverse events. Potential severe adverse events include:

• Vascular Occlusion (VO): Although the risk is lower with superficial injection, accidental intravascular injection is still possible, particularly in high-risk areas (e.g., glabella, periorbital). Prompt recognition and management are crucial.
• Severe allergic reactions or hypersensitivity
• Inflammation or infection at injection sites
• Persistent nodules or granuloma formation (rare)
• Skin discoloration (Tyndall effect if injected too superficially)
• Herpetic eruptions (cold sores) in susceptible individuals

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation.